BRIEF published on 04/09/2024 at 11:32, 1 year 10 months ago GRAMMER AG Reports Decline in First Quarter Earnings for 2024 Financial Performance Automotive Industry Earnings Report Q1 2024 Earnings GRAMMER AG
BRIEF published on 04/09/2024 at 11:32, 1 year 10 months ago GRAMMER AG annonce une baisse de ses bénéfices au premier trimestre 2024 Performance Financière Industrie Automobile Rapport Sur Les Revenus GRAMMER AG Résultats Du Premier Trimestre 2024
BRIEF published on 04/09/2024 at 11:29, 1 year 10 months ago New Star Investment Trust PLC Reports Latest NAV Figures Asset Management Financial Report New Star Investment Trust PLC NAV Investment Trust
BRIEF published on 04/09/2024 at 11:29, 1 year 10 months ago New Star Investment Trust PLC publie ses derniers chiffres de valeur liquidative Rapport Financier VNI Nouveau Star Investment Trust PLC Fiducie D'investissement La Gestion D'actifs
BRIEF published on 04/09/2024 at 11:07, 1 year 10 months ago La société FREY actualise les informations sur ses droits de vote et son capital Autorité Des Marchés Financiers Droits De Vote Capital Social Code De Commerce FREY
BRIEF published on 04/09/2024 at 11:07, 1 year 10 months ago The FREY company updates information on its voting rights and capital Share Capital Voting Rights Financial Markets Authority FREY Trade Code
BRIEF published on 04/09/2024 at 10:27, 1 year 10 months ago Edison Highlights Accretive Portfolio Repositioning of Picton Property Income Investment Strategy Picton Property Income Accretive Portfolio Repositioning Office Sector Property Divestment
BRIEF published on 04/09/2024 at 10:27, 1 year 10 months ago Edison met en avant le repositionnement du portefeuille relutif de Picton Property Income Stratégie D'investissement Revenus Fonciers À Picton Repositionnement Du Portefeuille Relutif Secteur Bureaux Cession De Propriété
BRIEF published on 04/09/2024 at 10:05, 1 year 10 months ago G.ST Antivirals Begins Phase II Trial and Names Ronald Bruce Turner Chief Medical Officer G.ST Antivirals 2-Deoxy-D-glucose Respiratory Infections Phase II Trial Ronald Bruce Turner
BRIEF published on 04/09/2024 at 10:05, 1 year 10 months ago G.ST Antivirals commence l'essai de phase II et nomme Ronald Bruce Turner médecin-chef Essai De Phase II Ronald Bruce Turner Antiviraux G.ST 2-Désoxy-D-glucose Infections Respiratoires
Published on 03/07/2026 at 00:00, 9 hours 38 minutes ago Green Bridge Metals to Ship Titac Drill Core for Metallurgical Testing to Evaluate Titanium Dioxide Extraction Potential
Published on 03/06/2026 at 22:30, 11 hours 8 minutes ago Sceptre Ventures Announces Amendment and Closing of Private Placement Offering
Published on 03/06/2026 at 22:00, 11 hours 38 minutes ago Pegasus Resources Inc. Announces Annual General and Special Meeting of Shareholders
Published on 03/06/2026 at 17:55, 15 hours 43 minutes ago High Tide Resources Announces Upsize to Private Placement
Published on 03/06/2026 at 14:00, 19 hours 38 minutes ago CHAR Technologies Announces Increase to C$ 3.97M and Closing of Book on Previously Announced Private Placement
Published on 03/07/2026 at 02:03, 7 hours 35 minutes ago EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Published on 03/06/2026 at 23:05, 10 hours 33 minutes ago DeFi Technologies Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Published on 03/06/2026 at 19:30, 14 hours 8 minutes ago TRADE SHOWS: IEG, OUTSTANDING RESULTS FOR KEY - THE ENERGY TRANSITION EXPO WITH +10% TOTAL VISITORS AND +9% FROM ABROAD
Published on 03/06/2026 at 18:44, 14 hours 53 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/06/2026 at 18:30, 15 hours 8 minutes ago WHO Foundation announces collaboration with Lilly to strengthen health systems for obesity care
Published on 03/06/2026 at 18:05, 15 hours 33 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 28/02/2026
Published on 03/06/2026 at 18:05, 15 hours 33 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 28/02/2026
Published on 03/06/2026 at 18:00, 15 hours 38 minutes ago Outstanding shares and voting rights statement at 28 February 2026
Published on 03/06/2026 at 18:00, 15 hours 38 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 28 février 2026
Published on 03/06/2026 at 18:00, 15 hours 38 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 27 février 2026
